Biomarkers in the clinical diagnosis and management of traumatic brain injury (Q45061432)

9 December 2017

title

Biomarkers in the clinical diagnosis and management of traumatic brain injury (English)

1 reference

9 December 2017

0 references

traumatic brain injury

0 references

author

Georgene W. Hergenroeder

series ordinal

1

1 reference

9 December 2017

John B Redell

2

1 reference

9 December 2017

Anthony N Moore

series ordinal

3

1 reference

9 December 2017

Pramod K Dash

series ordinal

4

1 reference

9 December 2017

publication date

1 January 2008

1 reference

Molecular Diagnosis and Therapy

9 December 2017

published in

1 reference

9 December 2017

volume

12

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

345-358

1 reference

Epidemiology of head injury.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Understanding combat casualty care statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Assessment of coma and impaired consciousness. A practical scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Magnetic resonance imaging in minor head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Indications for computed tomography in patients with minor head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Accuracy of mild traumatic brain injury diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Mild traumatic brain injury in U.S. Soldiers returning from Iraq.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Impact of early intervention on outcome after mild traumatic brain injury in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Impact of early intervention on outcome following mild head injury in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Mild head injury: facts and artifacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Cranial imaging in child abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

The shaken baby syndrome. A clinical, pathological, and biomechanical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Are abused babies protected from further abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Time course of intracranial hypertension after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Refractory intracranial hypertension and "second-tier" therapies in traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Treatment of postconcussional symptoms with CDP-choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Effect of severity of post-traumatic confusion and its constituent symptoms on outcome after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Enrichment of low-abundance brain proteins by preparative electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Proteomic analysis of human ventricular cerebrospinal fluid from neurologically normal, elderly subjects using two-dimensional LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Soluble adhesion molecules in CSF are increased in children with severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

The diagnostic applications of saliva--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Current two-dimensional electrophoresis technology for proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

The proteome of dissimilatory metal-reducing microorganism Geobacter sulfurreducens under various growth conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Proteomic identification of biomarkers of traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Proteomic analysis of serum cytokine levels in response to highly active antiretroviral therapy (HAART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serum proteomic patterns for detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

On linear combinations of biomarkers to improve diagnostic accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

S100B serum level predicts computed tomography findings after minor head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serum markers of brain damage and outcome prediction in patients after severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serum S-100B protein in severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

S-100beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Raised serum S100B levels after acute bone fractures without cerebral injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Clinical significance of serum S100B levels in neurointensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Neuron-specific enolase as an aid to outcome prediction in head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Correlation of computed tomography findings and serum brain damage markers following severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Early elevation of S-100B protein in blood after cardiac surgery is not a predictor of ischemic cerebral injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Spectrin breakdown products in the cerebrospinal fluid in severe head injury--preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Biomarkers of proteolytic damage following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Discordant temporal patterns of S100beta and cleaved tau protein elevation after head injury: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serum biomarker concentrations and outcome after pediatric traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Proteolysis of multiple myelin basic protein isoforms after neurotrauma: characterization by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Cerebral blood flow velocity and inflammatory response after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Age-dependent synuclein pathology following traumatic brain injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Protein Accumulation in Traumatic Brain Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Synuclein aggregation: possible role in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Low-dose prostacyclin in treatment of severe brain trauma evaluated with microdialysis and jugular bulb oxygen measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Monitoring of serum ionized magnesium in neurosurgical intensive care unit: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Biochemical and clinical improvement of cytotoxic state by amantadine sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Severe human traumatic brain injury, but not cyclosporin a treatment, depresses activated T lymphocytes early after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

A critical analysis of the role of the neurotrophic protein S100B in acute brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Effects of head and extracranial injuries on serum protein S100B levels in trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Assessment of cerebral S100B levels by proton magnetic resonance spectroscopy after lateral fluid-percussion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Neurological injury markers in children with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Cellular fatty acid-binding proteins: their function and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Factors associated with neurological outcome and lesion progression in traumatic subarachnoid hemorrhage patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Which CT features help predict outcome after head injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Current aspects of pathophysiology and cell dysfunction after severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Increases in bcl-2 protein in cerebrospinal fluid and evidence for programmed cell death in infants and children after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Continuous Versus Intermittent Cerebrospinal Fluid Drainage after Severe Traumatic Brain Injury in Children: Effect on Biochemical Markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256301

Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury.

21 January 2018

1 reference

12 December 2020

Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA

1 reference

12 December 2020

S100B in Guillain–Barré syndrome

1 reference

12 December 2020

A Comparative Study of Saliva and OraSure® Oral Fluid

1 reference

12 December 2020

Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.

1 reference

12 December 2020

Serum S-100B protein as a molecular marker in severe traumatic brain injury

1 reference

12 December 2020

Comparison of serial S-100 and NSE serum measurements after severe head injury

1 reference

12 December 2020

Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer

1 reference

12 December 2020

Glial and neuronal serum markers after controlled cortical impact injury in the rat.

1 reference

12 December 2020

Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds

1 reference

12 December 2020

Estimation of brain lesion size based on quantifying CK-BB release.

1 reference

12 December 2020

The use of controlled mild hypothermia and immune system status in patients with severe brain injury.

1 reference

12 December 2020

High serum S100B levels for trauma patients without head injuries

1 reference

12 December 2020

New biochemical markers for myocardial cell injury

1 reference

12 December 2020

Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

1 reference

12 December 2020

Evaluation of Salivary Antibodies to Detect Infection with Helicobacter pylori

1 reference

12 December 2020

Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury

1 reference

12 December 2020

Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers

1 reference

12 December 2020

Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury

1 reference

12 December 2020

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

1 reference

12 December 2020

A newly developed PCR assay of H. pylori in gastric biopsy, saliva, and feces. Evidence of high prevalence of H. pylori in saliva supports oral transmission

1 reference

12 December 2020

Serum neuron-specific enolase as a predictor of intracranial lesions in children with head trauma: a pilot study

1 reference

12 December 2020

Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions

1 reference

12 December 2020

Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children

1 reference

12 December 2020

Biochemical Markers of Cerebral Injury in Patients with Minor Head Trauma and Ethanol Intoxication

1 reference

12 December 2020

RCA-enhanced protein detection arrays

1 reference

12 December 2020

Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results

1 reference

12 December 2020

Definition of a sequence unique in beta II spectrin required for its axon-specific interaction with fodaxin (A60).

1 reference

12 December 2020

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children

1 reference

12 December 2020

Biomarker discovery in biological fluids

1 reference

12 December 2020

Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis

1 reference

12 December 2020

The effect of head injury upon the immune system.

1 reference

12 December 2020

Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury

1 reference

12 December 2020

Early and late systemic hypotension as a frequent and fundamental source of cerebral ischemia following severe brain injury in the Traumatic Coma Data Bank

1 reference

12 December 2020

Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.

1 reference

12 December 2020

Serum S100B concentrations are increased after closed head injury in children: a preliminary study

1 reference

12 December 2020

Biochemical markers of brain injury: could they be used as diagnostic adjuncts in cases of inflicted traumatic brain injury?

1 reference

12 December 2020

Traumatic brain injury in the war zone

1 reference

12 December 2020

Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.

1 reference

12 December 2020

Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography

1 reference

12 December 2020

False-positive oral fluid rapid HIV tests--New York City, 2005-2008.

1 reference

12 December 2020

Sequelae of minor traumatic brain injury

1 reference

12 December 2020

Increases of Neuron-specific Enolase, S-100 Protein, Creatine Kinase and Creatine Kinase BB isoenzyme in CSF following intraventricular catheter implantation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256301

1 reference

Dimensions Publication ID

9 December 2017

1036051877

0 references

1 reference